Immunotherapy
-
{
- All
- News
- Videos
-
Unexpected Immune System Mechanism Found To Attack Cancer, Scientists Reveal
Many modern cancer treatments, including immunotherapy, depend on activating killer T cells to recognise and destroy tumours.
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
-
New Drug-Vaccine Combo Cuts Melanoma Recurrence Risk By Nearly 50%, Finds Study
Researchers have found that a combination of a personalised cancer vaccine and an immunotherapy drug can significantly lower the chances of the disease returning after surgery. This treatment has shown benefits, even after five years of follow-up.
-
Are Some Cancers Worse Than Others? What Scientists Say
Scientists say some cancers are biologically more aggressive than others, but outcomes depend on many factors including tumour type, stage, genetics, treatment response, and early detection.
-
7-Minute Cancer Shot Costing Rs 3.7 Lakh Per Dose Launched In India
The new injection uses a drug called atezolizumab, which works by blocking a protein called PD-L1. Cancer cells use this protein to hide from the immune system. Once the protein is blocked, the body's immune cells can identify and attack cancer cells
-
HIV Study: Boosting Immune Cells May Help Fight Infection
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
-
Low-Dose Peanut Therapy Helps Most Allergic Preschoolers: Lancet Study
A landmark trial has found that low-dose peanut oral immunotherapy safely desensitised more than 82% of preschool children with peanut allergy. Researchers say the gradual approach may offer a safer path to long-term allergy tolerance.
-
Jurassic Park Star Sam Neill Is Cancer-Free After Chemotherapy Failed; How CAR T-Cell Therapy Worked
Sam Neill had been undergoing chemotherapy for years, but the treatment eventually became ineffective. At one point, he described his condition as critical.
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Chemotherapy Vs Immunotherapy: What's The Difference In Cancer Care?
Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to continue their routine activities during treatment.
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
Breakthrough Brain Cancer Therapy Shows Dramatic Tumour Shrinking In 5 Days In Early Trial
CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing them back into the body.
-
Unexpected Immune System Mechanism Found To Attack Cancer, Scientists Reveal
Many modern cancer treatments, including immunotherapy, depend on activating killer T cells to recognise and destroy tumours.
-
Smart Cancer Drug Can Shrink Tumours By 30% In Early Trial
In an early-stage (Phase 1) trial of 83 patients, the drug shrank tumours in 26 people. For 15 of those patients, their tumours shrank by at least 30%.
-
New Drug-Vaccine Combo Cuts Melanoma Recurrence Risk By Nearly 50%, Finds Study
Researchers have found that a combination of a personalised cancer vaccine and an immunotherapy drug can significantly lower the chances of the disease returning after surgery. This treatment has shown benefits, even after five years of follow-up.
-
Are Some Cancers Worse Than Others? What Scientists Say
Scientists say some cancers are biologically more aggressive than others, but outcomes depend on many factors including tumour type, stage, genetics, treatment response, and early detection.
-
7-Minute Cancer Shot Costing Rs 3.7 Lakh Per Dose Launched In India
The new injection uses a drug called atezolizumab, which works by blocking a protein called PD-L1. Cancer cells use this protein to hide from the immune system. Once the protein is blocked, the body's immune cells can identify and attack cancer cells
-
HIV Study: Boosting Immune Cells May Help Fight Infection
Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells.
-
Low-Dose Peanut Therapy Helps Most Allergic Preschoolers: Lancet Study
A landmark trial has found that low-dose peanut oral immunotherapy safely desensitised more than 82% of preschool children with peanut allergy. Researchers say the gradual approach may offer a safer path to long-term allergy tolerance.
-
Jurassic Park Star Sam Neill Is Cancer-Free After Chemotherapy Failed; How CAR T-Cell Therapy Worked
Sam Neill had been undergoing chemotherapy for years, but the treatment eventually became ineffective. At one point, he described his condition as critical.
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Chemotherapy Vs Immunotherapy: What's The Difference In Cancer Care?
Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to continue their routine activities during treatment.
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
From Surgery To Immunotherapy: Doctor Explains Advances In Oral Cancer Treatment
A major shift in recent years is the use of immunotherapy earlier in the treatment process, even before surgery. This is known as neoadjuvant immunotherapy.
-
Breakthrough Brain Cancer Therapy Shows Dramatic Tumour Shrinking In 5 Days In Early Trial
CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing them back into the body.
